Stem Cell/Creative Commons
Media buzz is swirling around Dr. Thomas Einhorn for his successes with adult stem cells. What's the fuss all about and what does it mean for the future of biologics…and device manufacturers for that matter?
Amsterdam Canal / Image source: morgueFile.com
Every couple years these European scientists call a meeting to compare BMP and stem cell studies for the spine. Last meeting was 2007 in Leipzig. Their work is qualitatively quite different from the U.S. meetings. Now they are meeting again. In three weeks. In Amsterdam. You should go.
Medical devices developed with biomaterials. Source: NJ Center for Biomaterials
Last week OTW took you inside the Armed Forces' ambitious Institute of Regenerative Medicine (AFIRM) project. Now one of its leaders, the dynamic Dr. Joachim Kohn, talks about the high-tech New Jersey Biomaterials Center, current projects and how the research teams are playing nice together.
U.S. Soldiers in Sadr City/Wikimedia Commons
It's been two years since the Armed Forces Institute of Regenerative Medicine (AFIRM) formed. This unprecedented alliance of academic, clinical, industrial and military research teams has a singular goal: fast-tracking regenerative research into applicable therapies. So what exactly are they working on?
Meniscus Allograft / Three-year Post Menallo
The longest and largest prospective study of meniscal allograft transplants was published last week in the UK version of JBJS. Three different measurement systems all said that these patients improve significantly at two, three, five, seven and ten years. Interesting!
Image created by RRY Publications/Source: Regenexx, FDA
The Centeno-Schultz Clinic's Regenexx stem cell therapy is being marketed as a treatment for several orthopedic indications. What’s the FDA’s take? The answer will surprise.
Chick hatching/Creative Commons
What began as a way for one egg producer to cut down on waste has blossomed into a entire line of joint and bone supplements, all based around the common chicken egg.